In early September, the Engelberg Center for Health Care Reform released a report, Bending the Curve: Effective Steps to Address Long-Term Spending Growth, to help inform the current debate. The report—aimed at identifying a concrete and feasible set of steps to slow long-term growth in health care spending—was developed by a group of leading experts in health care and economics.
This brief provides a high-level review of the legislation introduced by Senate Finance Committee Chairman Max Baucus, including a side-by-side summary of key provisions of the Bending the Curve report and those in the Baucus proposal.
The Baucus health care reform proposal offers many promising ideas to improve the overall performance of the U.S. health care system. In addition to steps that would reduce the number of Americans without insurance coverage, the plan includes ways to slow long-term spending growth while building the high-value health care system our nation urgently needs.
We believe there are important opportunities to modify or augment this proposal to further ensure that payment systems, regulations, and institutions are reformed as part of a comprehensive strategy to increase accountability and support for lowering costs and improving quality. In this review, we briefly summarize: 1) aspects of the Baucus proposal that we believe have the greatest potential to slow long-term spending growth; 2) areas not directly included in the proposal that we believe should be addressed; and 3) other aspects of the plan where modifications could increase the effectiveness of the overall reform package.
As emphasized in Bending the Curve, the individual reforms described below—and in the report itself—should not be viewed as discrete, incremental steps that alone would slow long-term spending growth. Rather, these are interdependent and reinforcing reforms that should be implemented together to improve and modernize the U.S. health care system.
Fast track to recovery: US-China collaboration on COVID-19 prevention and treatment
On February 24, Vanda Felbab-Brown joins the National Committee on US-China Relations for a discussion on “The faces of fentanyl: China, the United States, and those in-between.”